These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin MC. Circ Cardiovasc Imaging; 2013 Jan 01; 6(1):83-90. PubMed ID: 23204039 [Abstract] [Full Text] [Related]
4. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM. Arch Dermatol; 2011 Sep 01; 147(9):1031-9. PubMed ID: 21576552 [Abstract] [Full Text] [Related]
5. Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography. Dey AK, Joshi AA, Chaturvedi A, Lerman JB, Aberra TM, Rodante JA, Teague HL, Harrington CL, Rivers JP, Chung JH, Kabbany MT, Natarajan B, Silverman JI, Ng Q, Sanda GE, Sorokin AV, Baumer Y, Gerson E, Prussick RB, Ehrlich A, Green LJ, Lockshin BN, Ahlman MA, Playford MP, Gelfand JM, Mehta NN. JAMA Cardiol; 2017 Sep 01; 2(9):1013-1018. PubMed ID: 28564678 [Abstract] [Full Text] [Related]
6. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis. Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Br J Dermatol; 2017 Mar 01; 176(3):732-740. PubMed ID: 27787888 [Abstract] [Full Text] [Related]
7. A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S). Gelfand JM, Shin DB, Duffin KC, Armstrong AW, Blauvelt A, Tyring SK, Menter A, Gottlieb S, Lockshin BN, Simpson EL, Kianifard F, Sarkar RP, Muscianisi E, Steadman J, Ahlman MA, Playford MP, Joshi AA, Dey AK, Werner TJ, Alavi A, Mehta NN. J Invest Dermatol; 2020 Sep 01; 140(9):1784-1793.e2. PubMed ID: 32088207 [Abstract] [Full Text] [Related]
9. Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study. Naik HB, Natarajan B, Stansky E, Ahlman MA, Teague H, Salahuddin T, Ng Q, Joshi AA, Krishnamoorthy P, Dave J, Rose SM, Doveikis J, Playford MP, Prussick RB, Ehrlich A, Kaplan MJ, Lockshin BN, Gelfand JM, Mehta NN. Arterioscler Thromb Vasc Biol; 2015 Dec 01; 35(12):2667-76. PubMed ID: 26449753 [Abstract] [Full Text] [Related]
10. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial. Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM. Circ Cardiovasc Imaging; 2018 Jun 01; 11(6):e007394. PubMed ID: 29776990 [Abstract] [Full Text] [Related]
11. Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis. Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Acta Derm Venereol; 2018 Apr 16; 98(4):390-395. PubMed ID: 29327063 [Abstract] [Full Text] [Related]
12. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN. Acad Radiol; 2015 May 16; 22(5):600-9. PubMed ID: 25708866 [Abstract] [Full Text] [Related]
13. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
14. Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative. Rose S, Dave J, Millo C, Naik HB, Siegel EL, Mehta NN. Arthritis Res Ther; 2014 Jul 30; 16(4):R161. PubMed ID: 25078679 [Abstract] [Full Text] [Related]
15. Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis. Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, Rodante JA, Aberra TM, Chung J, Salahuddin T, Natarajan B, Dave J, Goyal A, Groenendyk JW, Rivers JP, Baumer Y, Teague HL, Playford MP, Bluemke DA, Ahlman MA, Chen MY, Gelfand JM, Mehta NN. JAMA Cardiol; 2018 Oct 01; 3(10):949-956. PubMed ID: 30208407 [Abstract] [Full Text] [Related]
16. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM. J Am Acad Dermatol; 2019 Jun 01; 80(6):1630-1639. PubMed ID: 30654078 [Abstract] [Full Text] [Related]
17. Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and 18fluorodeoxyglucose (FDG) positron emission tomography (PET). Kim SJ, Park MY, Pak K, Han J, Kim GW, Kim HS, Ko HC, Kim MB, Kim BS. J Dermatolog Treat; 2018 Dec 01; 29(8):761-768. PubMed ID: 29658378 [Abstract] [Full Text] [Related]
18. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct 01; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A. Eur J Cardiothorac Surg; 2013 Aug 01; 44(2):e105-12. PubMed ID: 23674658 [Abstract] [Full Text] [Related]
20. Arterial Inflammation Detected With 18 F-Fluorodeoxyglucose-Positron Emission Tomography in Rheumatoid Arthritis. Geraldino-Pardilla L, Zartoshti A, Bag Ozbek A, Giles JT, Weinberg R, Kinkhabwala M, Bokhari S, Bathon JM. Arthritis Rheumatol; 2018 Jan 01; 70(1):30-39. PubMed ID: 28992382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]